SCHEMBL8310404

SCHEMBL8310404

C/C(=N/OCCOc1ccc(CC2SC(=O)N(C(c3ccccc3)(c3ccccc3)c3ccccc3)C2=O)cc1)c1ccc2ccccc2n1

nearest known ligand 0.44

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.44
ALOX5 P09917 2/20 0.36
RAB9A P51151 1/20 0.36
FFAR1 O14842 7/20 0.35
PPARA Q07869 3/20 0.34
RARG P13631 1/20 0.34
RXRA P19793 1/20 0.34
CYSLTR2 Q9NS75 1/20 0.33
CYSLTR1 Q9Y271 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8310405 1.00 PPARG (0.44) PPARGALOX5RAB9AFFAR1PPARA
SCHEMBL8306302 0.86 PPARG (0.49) PPARGFFAR1PPARA
SCHEMBL8306303 0.86 PPARG (0.49) PPARGFFAR1PPARA
SCHEMBL8306453 0.86 PPARG (0.49) PPARGFFAR1RARGRXRA
SCHEMBL8306456 0.86 PPARG (0.49) PPARGFFAR1RARGRXRA
SCHEMBL8305220 0.85 PPARG (0.46) PPARGFFAR1PPARARARGRXRA
SCHEMBL8305218 0.85 PPARG (0.46) PPARGFFAR1PPARARARGRXRA
SCHEMBL8307060 0.83 PPARG (0.55) PPARGFFAR1
SCHEMBL8307062 0.83 PPARG (0.55) PPARGFFAR1
SCHEMBL8305087 0.83 PPARG (0.51) PPARGFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed